Shanghai Jinfeng Wine L (600616.SS) traded flat 0 % during a 24 hours period ending at 04:58 PM Central Europe on Monday 26th. One Shanghai Jinfeng Wine L stock can currently be bought for about CNY 4.17 on popular exchanges. Current supply of Shanghai Jinfeng Wine L stocks is 669.1 mn. Shanghai Jinfeng Wine L has a current market capitalization of CNY 2.8 bn and approximately CNY 89.7 mn worth of Shanghai Jinfeng Wine L was traded on exchanges in the last 24 hours. Since last month end, Shanghai Jinfeng Wine L has traded -18.4 % down. Simple moving average of last 200 days is at CNY 4.33. The highest price of past 52 weeks was recorded at CNY 6 on 01/29/2026. 52 weeks low was at CNY 3.7 on 06/29/2026.
Summary of the latest news for Shanghai Jinfeng Wine L
Shanghai Jinfeng Wine Co. has experienced a notable decline in its share price in the recent trading week, mirroring broader market weakness within the domestic liquor sector. The company’s stock, which had attracted investor interest earlier in the period, fell by more than 14% during the week, reflecting a sharp reversal from its earlier gains. Analysts attribute the downturn to a combination of weaker-than‑expected first‑half earnings, a contraction in provincial sales, and a broader shift in the industry from supply‑side excess toward a more demand‑stable environment. In this context, Jinfeng Wine’s performance is seen as part of a larger pattern of sectoral consolidation, where only firms that can sustain robust demand and efficient inventory management are likely to maintain growth momentum.
Here is how related stocks have performed in the past 24 hours:
Citychamp Dartong Advanced M (600067.SS) traded flat 0 % and now trades at CNY 2.44. Current market capitalisation for Citychamp Dartong Advanced M is CNY 3.3 bn. Citychamp Dartong Advanced M has a current price to earnings ratio of 238.61.
Jacobio Grou (1167.HK) traded down -0.2 % and now trades at HKD 4.92. Jacobio Grou has a market capitalisation of HKD 3.9 bn. Current price/earnings ratio for Jacobio Grou is 6.59. AstraZeneca’s investigational antibody‑drug conjugate, sonesitatug vedotin, achieved a notable improvement in overall survival for patients with CLDN18.2‑positive advanced gastric or gastro‑esophageal junction cancers in a phase III trial. The study, which evaluated the drug in second‑line and later settings, reported a meaningful reduction in mortality risk compared with standard investigator‑chosen therapies. While the progression‑free survival endpoint did not reach statistical significance, the overall survival benefit was consistent across key patient subgroups and was achieved with a manageable safety profile. These results support the potential of sonesitatug vedotin as a new therapeutic option for this patient population and may influence future clinical practice in the treatment of advanced gastric cancers.
Bgrimm (600980.SS) traded flat 0 % and now trades at CNY 18.95. Bgrimm has a market capitalisation of CNY 3.3 bn. Bgrimm has a current price to earnings ratio of 23.13. BGRIMM TECHNOLOGY CO., LTD. reported a significant uptick in investor interest this week, reflected in a sharp rise in share price during the early trading session. Market data indicates that institutional capital has flowed strongly into the firm, positioning BGRIMM among the top recipients of net inflows in the sector. Analysts note that this momentum aligns with broader positive sentiment surrounding the robotics industry, which has experienced notable gains across related segments. The company’s performance is being viewed in the context of expanding global demand for robotic solutions, particularly in manufacturing and service applications. While specific earnings or valuation metrics are not disclosed, the trend suggests that BGRIMM’s valuation is being driven by perceived growth prospects in a sector that continues to attract substantial investment and customer interest.
Anshan Senyuan Road & Brid (300210.SZ) traded flat 0 % and now trades at CNY 6.9. Current market capitalisation for Anshan Senyuan Road & Brid is CNY 3.3 bn.
Jiangtianchemical (300927.SZ) traded flat 0 % and now trades at CNY 22.78. Jiangtianchemical has a market capitalisation of CNY 3.3 bn. Current price/earnings ratio for Jiangtianchemical is 54.93.
About Shanghai Jinfeng Wine L
Shanghai Jinfeng Wine Co., Ltd. is a consumer staples company based in China with its main operations in Shanghai. The company is involved in food retailing, producing wines and sugar, and operating restaurants. You can find more information about the company on their website, www.firstfood.com.cn , and they are listed on the Shanghai Stock Exchange. Their IPO date is June 13, 1992.